Trial Profile
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jul 2013
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Friedreich's ataxia; Machado-Joseph Disease
- Focus Therapeutic Use
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Mar 2012 Planned End Date changed from 1 Mar 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 09 Sep 2011 Actual initiation date Aug 2011 added as reported by ClinicalTrials.gov.